| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |